Technical Analysis for CLIN - Clinigen Group Plc

Grade Last Price % Change Price Change
B 722.5 -0.21% -1.50
CLIN closed up 1.97 percent on Monday, January 18, 2021, on 51 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical CLIN trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish -0.21%
20 DMA Support Bullish -0.21%
Slingshot Bullish Bullish Swing Setup -0.21%
Stochastic Reached Overbought Strength -0.21%
Overbought Stochastic Strength -0.21%
200 DMA Support Bullish 1.76%
20 DMA Support Bullish 1.76%
Upper Bollinger Band Touch Strength 1.76%
200 DMA Support Bullish 0.28%
20 DMA Support Bullish 0.28%
Older End-of-Day Signals for CLIN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low about 23 hours ago
Down 3% about 23 hours ago
Down 2% about 23 hours ago
Down 1% about 23 hours ago
Reversed from Down about 23 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Clinigen Group Plc Description

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.


Sector: Healthcare
Industry: Medical Distribution
Keywords: Health Healthcare Pharmaceutical Consultancy Biotechnology Medicine Clinic Pharmaceuticals Hospital Drugs Clinical Trial Pharmaceutical Industry Therapies Rescue Pharmaceutical Products Clinical Research Medication Pharmaceutical Companies Pharmaceutical Industry In China Pharmaceuticals Policy Medical Products Idis Clinical Trial Services Design Of Experiments

Is CLIN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1000.0
52 Week Low 350.4
Average Volume 285,392
200-Day Moving Average 694.88
50-Day Moving Average 664.29
20-Day Moving Average 691.73
10-Day Moving Average 709.25
Average True Range 33.02
ADX 15.78
+DI 15.59
-DI 16.10
Chandelier Exit (Long, 3 ATRs ) 634.44
Chandelier Exit (Short, 3 ATRs ) 731.56
Upper Bollinger Band 732.41
Lower Bollinger Band 651.04
Percent B (%b) 0.9
BandWidth 11.76
MACD Line 16.61
MACD Signal Line 15.03
MACD Histogram 1.578
Fundamentals Value
Market Cap 96.31 Billion
Num Shares 133 Million
EPS 10.20
Price-to-Earnings (P/E) Ratio 70.98
Price-to-Sales 1.72
Price-to-Book 1.92
PEG Ratio 0.00
Dividend 0.08
Dividend Yield 0.01%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 799.75
Resistance 3 (R3) 792.17 759.33 787.13
Resistance 2 (R2) 759.33 740.04 763.13 782.91
Resistance 1 (R1) 741.67 728.12 750.50 749.25 778.71
Pivot Point 708.83 708.83 713.25 712.63 708.83
Support 1 (S1) 691.17 689.54 700.00 698.75 669.29
Support 2 (S2) 658.33 677.62 662.13 665.09
Support 3 (S3) 640.67 658.33 660.88
Support 4 (S4) 648.25